Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial
Jinfeng Zhang, Yongqiang Yang, Zilong Wu, Sisi Zhang, Zhenyu Lin, Hongli Liu, Jianli Hu, Tao Zhang, Jing Tang, Jun Xue
BMJ Open Jun 2024, 14 (6) e077903; DOI: 10.1136/bmjopen-2023-077903